Strategic deals drive Catalent’s $410m move for Aptuit assets
Catalent is to buy clinical trial supply assets from Aptuit for $410m (€285m) as it adds scale to handle the shift to preferred provider relationships.
Archives for August 22, 2011
Brazil & USP ink deals to up quality, harmonise standards
The USP is strengthening ties to the Brazilian pharmaceutical sector to improve quality and drive harmonisation of standards.
Rise of Chinese pharma helps ShangPharma grow in Q2
China-based clients now account for 10 per cent of ShangPharma revenues after successive quarters of triple-digit sales growth.
Clinigene and Spaulding team up on pharmacology services
Biocon’s Indian unit Clinigene International has partnered with US counterpart Spaulding Clinical Research LLC to provide clinical pharmacology services.
Needle-free drug delivery is the wave of the future, says Kalorama
The worldwide market for needle-free drug delivery will double in value over the next five years, according to new market research by Kalorama.
Takeda gets 24bn yen Govt grant for cell culture vacc plant
Japanese drugmaker Takeda has been awarded JPY24bn ($313m) to develop and a cell culture influenza vaccine and establish a commercial-scale production facility.